MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Lymphoma Diagnosis and Treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,251 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,251 works in the cohort · of 4,299,418page 28 of 66

Labels cover 5 of 3,251 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,251 of 3,251 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundno abstractunlabeled
DNA Methylation-Based Classification of Small B-Cell Lymphomas
Daniel Xia, Alberto J. León, Jiong Yan, Anjali Silva, Mehran Bakhtiari, Rosemarie Tremblay‐LeMay +6 more
2021· article· en· Journal of Molecular Diagnostics· Medicine
machine prediction:candidate · noneconsensus · none
11
citations
affno abstractunlabeled
Hodgkin Lymphoma of the Oral Mucosa
Mark Darling, Karl Cuddy, Kamilia Rizkalla
2012· article· en· Head and Neck Pathology· Medicine
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
Cost–effectiveness of rituximab in follicular lymphoma
Karissa Johnston, Corneliu Bolbocean, Joseph M. Connors, Stuart Peacock
2012· review· en· Expert Review of Pharmacoeconomics & Outcomes Research· Medicine
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
The POLARIX Study: Polatuzumab Vedotin with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
Hervé Tilly, Franck Morschhauser, Laurie H. Sehn, Jonathan W. Friedberg, Marek Trněný, Jeff P. Sharman +26 more
2021· article· en· Blood· Medicine
machine prediction:candidate · noneconsensus · none
10
citations
affunlabeled
ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma
Bouthaina S. Dabaja, Ranjana H. Advani, David Hodgson, Sughosh Dhakal, Christopher R. Flowers, Chul S. Ha +11 more
2015· review· en· American Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
10
citations

How this was built: Screen · Findings · About